- Home
- NBTX vs UDMY Comparison
NBTX vs UDMY Comparison
Compare NBTX & UDMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NBTX | UDMY |
|---|---|---|
| Founded | 2003 | 2009 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NBTX | UDMY |
|---|---|---|
| Price | $22.35 | $5.35 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 9 |
| Target Price | $8.00 | ★ $9.63 |
| AVG Volume (30 Days) | 46.3K | ★ 1.6M |
| Earning Date | 09-30-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $11,930,711.00 | ★ $795,801,000.00 |
| Revenue This Year | N/A | $2.34 |
| Revenue Next Year | $136.64 | $2.54 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 2.53 |
| 52 Week Low | $2.82 | $4.86 |
| 52 Week High | $30.35 | $10.61 |
Technical Indicators
Market Signals| Indicator | NBTX | UDMY |
|---|---|---|
| Relative Strength Index (RSI) | 57.88 | 49.27 |
| Support Level | $20.83 | $5.02 |
| Resistance Level | $22.05 | $5.40 |
| Average True Range (ATR) | 0.89 | 0.15 |
| MACD | 0.07 | 0.09 |
| Stochastic Oscillator | 88.34 | 91.35 |
Price Performance
Historical ComparisonAbout NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
About UDMY Udemy Inc.
Udemy Inc operates a marketplace platform at the center of a vibrant knowledge network. The company operates under two operating and reportable segments Consumer and Enterprise, out of which the Enterprise segment derives the maximum revenue. Geographically, the company derives maximum revenue from North America. The company leverages data, technology, and insights for effective learning experiences. It helps individuals and organizations to possess effective skill acquisition and development with flexibility.